There is a close relationship between chronic stress,
glucocorticoids and depression. Psychiatric and
cognitive symptoms resembling major depression have been observed in patients experiencing elevated
glucocorticoid levels, and a high percentage of people suffering from depression have undergone a stressful event/events prior to the onset of this
mental disorder. In our study, we investigated whether acute and chronic treatment of
dexamethasone induces depression-like behavior in mice and if
dexamethasone therapy influences the activity of
antidepressant drugs with diverse modes of action. The
antidepressant-like effect was assessed by the forced swim test in adult mice. The depressogenic-like activity of
dexamethasone turned out to be dose-dependent: only the highest tested dose of the
glucocorticoid (i.e., 64μg/kg) given as a single injection increased immobility time, whereas 16μg/kg/day of
dexamethasone (but not 4μg/kg/day) administered repeatedly induced a significant alteration in animal behavior. These depressogenic doses of
dexamethasone (i.e., 64μg/kg and 16μg/kg/day for an acute and repeated administration, respectively) diminished the
antidepressant potential of the therapeutic doses of
imipramine (10mg/kg),
amitriptyline (10mg/kg),
tianeptine (25mg/kg),
mianserin (10mg/kg),
citalopram (15mg/kg) and
moclobemide (25mg/kg). Two main findings of our study should be particularly underlined: (1) both single and repeated administration of
dexamethasone evoked a depression-like behavior of mice, (2) both single and repeated administration of
dexamethasone were able to modify the activity of the
antidepressant agents from various pharmacological groups, which may lead to a considerable reduction in the efficacy of
pharmacotherapy prescribed for patients with
mood disorders.